Treatment of Advanced NSCLC with Unknown EGFR Gene Status
__ TKI or Chemotherapy?

Treatment of Advanced NSCLC with Unknown EGFR Gene Status
__ TKI or Chemotherapy?

At present, the treatment recommendations of advanced non-small cell lung cancer (NSCLC) with clear epidermal growth factor receptor (EGFR) gene status has reached a consensus: patients with EGFR mutation-positive NSCLC can give priority to epidermal growth factor receptor-tyrosine kinase inhibitors...

Full description

Bibliographic Details
Main Authors: Xiaoqing LIU, Jing XU
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2014-10-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplams
Unknown EGFR gene status
EGFR-TKIs
Chemotherapy
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2014.10.01

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2014.10.01

Similar Items